Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China flag China · Delayed Price · Currency is CNY
32.63
-0.27 (-0.82%)
At close: Feb 13, 2026

SHA:688139 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
691.84901.231,269951.78774.391,849
Trading Asset Securities
653.41877.25651.142,0242,130408.03
Cash & Short-Term Investments
1,3451,7781,9202,9752,9042,257
Cash Growth
-27.28%-7.39%-35.46%2.45%28.69%-0.54%
Accounts Receivable
461.32352.76208.35192.17136.29182.61
Other Receivables
7.698.567.473.993220.38
Receivables
469.01361.32215.82196.16168.29202.98
Inventory
316.65334.74248.02270.55345.75247.95
Prepaid Expenses
-0.142.561.210.410.97
Other Current Assets
419.16177.77149.2145.1938.2325.36
Total Current Assets
2,5502,6522,5363,4893,4572,734
Property, Plant & Equipment
930.12915.18862.22802.08464.13343.6
Long-Term Investments
245.44972.711,030371.85358.34261.19
Goodwill
758.39757.87642.68451.3323.45323.85
Other Intangible Assets
369.91402.3367.73312.35241.62214.6
Long-Term Deferred Tax Assets
83.1766.0151.6730.5235.4347.23
Long-Term Deferred Charges
6.156.725.695.460.51.27
Other Long-Term Assets
707.1814.2429.1826.9119.5316.89
Total Assets
5,6505,7875,5265,4894,9003,943
Accounts Payable
415.36427.6390.98485.06431.57448.09
Accrued Expenses
75.42228.65235.15245.6196.05184.35
Short-Term Debt
10.0110.016.0110.01-25
Current Portion of Leases
-5.763.425.481.65-
Current Income Taxes Payable
48.5935.2135.828.6848.0140.3
Current Unearned Revenue
92.61151.98111.81232.84362.05247.82
Other Current Liabilities
284.31163.2158.51176.81104.1798.8
Total Current Liabilities
926.291,022941.661,1841,1441,044
Long-Term Leases
6.747.438.6910.674.32-
Long-Term Unearned Revenue
20.7223.1728.6232.8832.1832.65
Long-Term Deferred Tax Liabilities
47.5452.5146.9943.5925.929.43
Other Long-Term Liabilities
63.7863.8159.7569.0355.1851.65
Total Liabilities
1,0651,1691,0861,3411,2611,158
Common Stock
317.95317.95317.95317.95317.07317.07
Additional Paid-In Capital
1,9821,9771,9871,9951,9131,876
Retained Earnings
2,2702,2192,0151,7511,309584.29
Treasury Stock
-231.89-140.2-99.74-98.07--
Comprehensive Income & Other
-2.4-2.6910.3753.8984.34-1.01
Total Common Equity
4,3364,3724,2314,0213,6232,776
Minority Interest
249.75246.59209.25127.7115.958.64
Shareholders' Equity
4,5854,6184,4404,1483,6392,785
Total Liabilities & Equity
5,6505,7875,5265,4894,9003,943
Total Debt
16.7423.218.1126.155.9725
Net Cash (Debt)
1,3291,7551,9022,9492,8982,232
Net Cash Growth
-27.09%-7.73%-35.50%1.76%29.86%-1.64%
Net Cash Per Share
4.215.556.009.289.126.85
Filing Date Shares Outstanding
312.27314.48315.68316.49317.07317.07
Total Common Shares Outstanding
312.27314.48316.47316.49317.07317.07
Working Capital
1,6241,6301,5942,3042,3131,690
Book Value Per Share
13.8813.9013.3712.7011.438.75
Tangible Book Value
3,2073,2113,2203,2573,0582,237
Tangible Book Value Per Share
10.2710.2110.1810.299.647.06
Buildings
-696.63649.88257.73243.72230.31
Machinery
-333.52284.75240.79151.04122.68
Construction In Progress
-95.0370.33389.34130.9632.86
Source: S&P Global Market Intelligence. Standard template. Financial Sources.